December 26, 2019
Via: CNBCMigraine sufferers now have a new tool in their arsenal to fight the debilitating headaches with federal approval of Allergan’s first oral medication proven to ease migraine symptoms within two hours — even after they’ve started. The Food and Drug […]
October 23, 2019
Via: CNBCBiogen CEO Michel Vounatsos told CNBC on Wednesday that he is “reasonably confident” the U.S. Food and Drug Administration will approve the drugmaker’s experimental Alzheimer’s drug. “We worked in full transparency with the regulator,” Vounatsos told “Squawk Box,” emphasizing the […]
March 28, 2024
April 19, 2024
Copyright © 2024. All rights reserved
